PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine (CRSA), Paris, France.\', \'Laboratoire de Parasitologie-Mycologie, APHP, Hôpital Saint-Antoine, Paris, France.\', \'CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.\', \'Pneumologie Pédiatrique, APHP, Hôpital Trousseau, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.714027
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34950129
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Flagellin From Pseudomonas aeruginosa Modulates SARS-CoV-2 Infectivity in Cystic Fibrosis Airway Epithelial Cells by Increasing TMPRSS2 Expression.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all